▼ SELL
$ Value
$58K
Shares
1,513
Price
$38
Filed
Mar 3
Insider
Name
Stanton Marshall S.
Title
SVP, Clinical & MD Affair
CIK
0001849615
Roles
Officer
Transaction Details
Transaction Date
2026-03-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
40,408
Footnotes
These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Filing Info
Stanton Marshall S.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | AORT | ▼ | $81K |
| 2026-03-02 | AORT | ▼ | $58K |
| 2026-03-02 | AORT | A | $0 |
| 2026-02-24 | AORT | ▼ | $45K |
| 2026-02-23 | AORT | ▼ | $91K |
| 2025-11-21 | AORT | M | $374K |
| 2025-11-21 | AORT | ▼ | $655K |
| 2025-11-21 | AORT | ▼ | $259K |
| 2025-11-21 | AORT | M | $299K |
| 2025-11-21 | AORT | ▼ | $840K |
Other Insiders at AORT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Horton Amy
VP, Chief Accounting Officer
|
— | $153K | 2026-03-03 |
|
Mackin James P
President & CEO
|
— | $2.5M | 2026-03-03 |
|
Berry Lance A
EVP, COO, CFO & Treasurer
|
— | $783K | 2026-03-03 |
|
Holloway Jean F
SVP, General Counsel
|
— | $744K | 2026-03-04 |
|
Davis John E
Chief Commercial Officer
|
— | $494K | 2026-03-03 |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
— | $217K | 2026-03-03 |